<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01526668</url>
  </required_header>
  <id_info>
    <org_study_id>POSTHYSTREC</org_study_id>
    <nct_id>NCT01526668</nct_id>
  </id_info>
  <brief_title>Follow-up Strategies for Improved Postoperative Recovery After Benign Hysterectomy</brief_title>
  <acronym>POSTHYSTREC</acronym>
  <official_title>A Randomized Study Comparing Four Different Postoperative Follow-up Strategies for Improved Postoperative Recovery After Benign Hysterectomy</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Linkoeping</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital, Linkoeping</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of the study is to investigate the effect of four different follow-up strategies
      on postoperative recovery following vaginal or abdominal hysterectomy for benign conditions.
      Furthermore the investigators aim to examine associations between preoperative thresholds for
      pain (thermal and pressure) and postoperative pain and development of chronic pelvic pain
      after benign hysterectomy.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Contact sponsor if detailed information is requested.
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>October 2011</start_date>
  <completion_date type="Anticipated">December 2017</completion_date>
  <primary_completion_date type="Anticipated">December 2016</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Quality of life</measure>
    <time_frame>Six weeks</time_frame>
    <description>The Euroqol questionnaire form (EQ-5D) and Short-Form 36 (SF-36) are used for assessing the quality of life. Assessments preoperatively, once daily the first week postoperatively and then once weekly for additional five weeks.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Postoperative symptoms</measure>
    <time_frame>Six weeks</time_frame>
    <description>Selfreported symptoms in the Swedish Postoperative Symptom Questionnaire. Assessments preoperatively, once daily the first week postoperatively and then once weekly for additional five weeks.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Consumption of analgesic</measure>
    <time_frame>Six weeks</time_frame>
    <description>Total amount of opioids and non-opioids from surgery to six weeks postoperatively</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Complications related to operation</measure>
    <time_frame>Six weeks</time_frame>
    <description>From surgery to six weeks postoperatively</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Health economy</measure>
    <time_frame>Up to 1 years</time_frame>
    <description>Direct and indirect costs, quality adjusted life years (QALYs). From surgery to return to work</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Development of chronic pelvic pain</measure>
    <time_frame>One year</time_frame>
    <description>Development of chronic pelvic pain one year postoperatively among women with no pelvic pain preoperatively</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Duration of sick-leave</measure>
    <time_frame>Up to one year</time_frame>
    <description>Time from day of surgery to return to work at same level as preoperatively</description>
  </secondary_outcome>
  <number_of_arms>4</number_of_arms>
  <enrollment type="Anticipated">600</enrollment>
  <condition>Hysterectomy</condition>
  <condition>Genital Diseases, Female</condition>
  <condition>Pain</condition>
  <arm_group>
    <arm_group_label>No contact after discharge</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>In Arm A: The patient do not have planned contacts with the study nurse or doctor after discharge. All patients are seen by the study nurse six weeks postoperatively.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Single telephone contact</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>In Arm B: The patient has one planned telephone contact with the study nurse the day after discharge. All patients are seen by the study nurse six weeks postoperatively.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Telephone contacts regularly</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>In Arm C: The patient has planned telephone contacts with the study nurse the day after discharge and then once weekly until the six weeks follow-up visit postoperatively.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Telephone contact using CBT-inspired strategy</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>In Arm C: The patient has planned telephone contacts with the study nurse the day after discharge and then once weekly until the six weeks follow-up visit postoperatively. At these telephone contacts the study nurse uses a cognitive behavior therapy (CBT)-inspired strategy in counselling and support.</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Follow-up strategy</intervention_name>
    <description>Comparison of different follow-up strategies</description>
    <arm_group_label>Single telephone contact</arm_group_label>
    <arm_group_label>Telephone contacts regularly</arm_group_label>
    <arm_group_label>Telephone contact using CBT-inspired strategy</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>No contact after discharge</intervention_name>
    <arm_group_label>No contact after discharge</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Women between 18 and 60 years of age.

          -  Women who are scheduled for vaginal or abdominal total or subtotal hysterectomy for
             benign gynecological diseases (including cervical dysplasia).

          -  Women who understand and speak Swedish fluently.

          -  Women who gives signed informed consent to participate in the study.

          -  Women who have access to a telephone and/or internet.

        Exclusion Criteria:

          -  Women where the hysterectomy is carried out in association with surgery for genital
             prolapse

          -  Women with genital malignancies (does not include cervical dysplasia).

          -  Women where the operation is planned or expected to comprise more than the
             hysterectomy with or without unilateral salpingooophorectomy and appendectomy en
             passant.

          -  Women with previous bilateral salpingooophorectomy.

          -  Women who are physically disabled to a degree so that mobilization postoperatively
             cannot be expected as for a normal individual.

          -  Women who are mentally disabled to a degree so she cannot complete the forms in the
             study or understand the tenor of the participation or it is considered doubtful from
             an ethical point of view to participate.

          -  Women with psychiatric disease or is on medication for severe psychiatric disease so
             that the physician consider participation in the study unsuitable.

          -  Women with current drug or alcohol abuse.
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>60 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Preben Kjolhede, MD, PhD</last_name>
    <role>Study Chair</role>
    <affiliation>Department of Obstetrics and Gynecology, University Hospital, 58185 Linkoping, Sweden</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Ninnie Borendal Wodlin, MD, PhD</last_name>
    <role>Study Chair</role>
    <affiliation>Department of Obstetrics and Gynecology, University Hospital, S-58185 Linkoping, Sweden</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Lena Nilsson, MD, PhD</last_name>
    <role>Study Chair</role>
    <affiliation>Department of Anesthesiology, University Hospital, S-58185 Linkoping, Sweden</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Gunilla Sydsjo, PhD</last_name>
    <role>Study Chair</role>
    <affiliation>Department of Obstetrics and Gynecology, University Hospital, S-58185 Linkoping, Sweden</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Gulnara Kassymova, MD</last_name>
    <role>Study Chair</role>
    <affiliation>Department of Obstetrics and Gynecology, University Hospital, S-58185 Linkoping, Sweden</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Peter Lukas, MD</last_name>
    <role>Study Chair</role>
    <affiliation>Department of Obstetrics and Gynecology, University Hospital, S-58185 Linkoping, Sweden</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Björn Gerdle, MD, PhD</last_name>
    <role>Study Chair</role>
    <affiliation>Pain and Rehabilitation Center, University Hospital, 581 85 Linkoping, Sweden</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Preben Kjolhede, MD, PhD</last_name>
    <phone>+46101030000</phone>
    <phone_ext>3187</phone_ext>
    <email>Preben.Kjolhede@liu.se</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Ninnie Borendal Wodlin, MD, PhD</last_name>
    <phone>+46101030000</phone>
    <phone_ext>3133</phone_ext>
    <email>Ninnie.Borendal.Wodlin@regionostergotland.se</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Department of Obstetrics and Gynecology, Höglandshospital</name>
      <address>
        <city>Eksjo</city>
        <state>Jonkopings län</state>
        <zip>57533</zip>
        <country>Sweden</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Tomasz Stypa, MD</last_name>
      <phone>+4638135000</phone>
      <email>Tomasz.Stypa@rjl.se</email>
    </contact>
    <investigator>
      <last_name>Tomasz Stypa, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Department of Obstetrics and Gynecology, Ryhov Central Hospital</name>
      <address>
        <city>Jonkoping</city>
        <state>Jonkopings län</state>
        <zip>551 85</zip>
        <country>Sweden</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Laila Falknas, MD</last_name>
      <phone>+4636321000</phone>
      <email>Laila.Falknas@rjl.se</email>
    </contact>
    <investigator>
      <last_name>Laila Falknas, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Department of Obstetrics and Gynecology</name>
      <address>
        <city>Varnamo</city>
        <state>Jonkopings Län</state>
        <zip>331 85</zip>
        <country>Sweden</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Christina Gunnervik, MD</last_name>
      <phone>+46270697000</phone>
      <email>Christina.Gunnervik@rjl.se</email>
    </contact>
    <investigator>
      <last_name>Christina Gunnervik, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Department of Obstetrics and Gynecology, University Hospital</name>
      <address>
        <city>Linkoping</city>
        <state>Ostergotland</state>
        <zip>58185</zip>
        <country>Sweden</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Preben Kjolhede, MD, PhD</last_name>
      <phone>+46101030000</phone>
      <phone_ext>3187</phone_ext>
      <email>Preben.Kjolhede@liu.se</email>
    </contact>
    <contact_backup>
      <last_name>Ninnie Borendal Wodlin, MD, PhD</last_name>
      <phone>+46101030000</phone>
      <phone_ext>3133</phone_ext>
      <email>Ninnie.Borendal.Wodlin@regionostergotland.se</email>
    </contact_backup>
    <investigator>
      <last_name>Preben Kjolhede, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Ninnie Borendal Wodlin, MD, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Gulnara Kassymova, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Peter Lukas, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Department of Obstetrics and Gynecology, Vrinnevi Hospital</name>
      <address>
        <city>Norrkoping</city>
        <state>Ostergotland</state>
        <zip>60779</zip>
        <country>Sweden</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Leif Hidmark, MD</last_name>
      <phone>+46101030000</phone>
      <email>Leif.Hidmark@regionostergotland.se</email>
    </contact>
    <investigator>
      <last_name>Leif Hidmark, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Sweden</country>
  </location_countries>
  <verification_date>February 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 27, 2012</study_first_submitted>
  <study_first_submitted_qc>February 3, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 6, 2012</study_first_posted>
  <last_update_submitted>February 20, 2016</last_update_submitted>
  <last_update_submitted_qc>February 20, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">February 23, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University Hospital, Linkoeping</investigator_affiliation>
    <investigator_full_name>Preben Kjolhede, MD, professor</investigator_full_name>
    <investigator_title>Professor</investigator_title>
  </responsible_party>
  <keyword>Benign gynecological disease</keyword>
  <keyword>Surgery</keyword>
  <keyword>Postoperative follow-up strategy</keyword>
  <keyword>Pain threshold</keyword>
  <keyword>Chronic pelvic pain</keyword>
  <keyword>[E04.950.300.399]</keyword>
  <keyword>[C13.351.500]</keyword>
  <keyword>[F02.463.593.710.560]</keyword>
  <keyword>[N02.421.585.722.700]</keyword>
  <keyword>Postoperative Care</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Genital Diseases, Female</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

